Cite
HARVARD Citation
Inoue, Y. et al. (2021). Efficacy and safety of nintedanib in Japanese patients with progressive fibrosing interstitial lung diseases: Subgroup analysis of the randomised, double-blind, placebo-controlled, phase 3 INBUILD trial. Respiratory medicine. p. . [Online].